期刊文献+

诱导性多潜能干细胞的研究进展和应用前景 被引量:2

Research progress and application prospect of induced pluripotent stem cells
下载PDF
导出
摘要 研究证实采用体外导入Oct4、Sox2、c-Myc和Klf4等4个转录因子可将小鼠体细胞直接重构成为ES细胞样的多潜能细胞,这类细胞被命名为诱导性多潜能干细胞(iPS细胞).同样,转染上述因子或Oct4、Sox2、Nanog、LIN28等4个因子也能够使人类体细胞重构为iPS细胞,后者与人类ES细胞的基本特征相似.据报道,由于转染基因c-Myc的重新激活可使嵌合体和子代小鼠的肿瘤发生增加,故近期建立了一种仅使用3个因子(Oct4、Sox2和Klf4)的改良方案,也可将成年小鼠和成人皮肤成纤维细胞诱导转化为iPS细胞.近期文献资料表明,人类iPS细胞系对于制备疾病的新模型和药物研究有帮助,但其用于移植治疗的应用前景则需要进一步加以考证. Recent reports demonstrate that mouse somatic cells can be directly reprogrammed into pluripotent embryonic stem (ES) cell-like cells by in vitro introduction of four transcription factors, Oct4, Sox2, c-Myc and Klf4. These cells are designated as induced pluripotent stem (iPS) cells. Similarly, the transfection with these four transcription factors or a cocktail of Oct4, Sox2, Nanog and LIN28 has been shown to be sufficient to reprogram human somatic cells to iPS cells that are indistinguishable from human ES cells. Since reactivation of the c-Myc transgene has been reported to increase tumorigenicity in the chimeras and progeny mice, a modified protocol with only three factors (Oct4, Sox2 and Klf4) has been recently used to make mouse and human iPS cells from adult dermal fibroblasts. Based upon the data from recent publications,human iPS cell lines should be useful in the establishment of new disease models and in drug development, and might require further investigation about the feasibility in transplantation medicine.
出处 《世界华人消化杂志》 CAS 北大核心 2008年第12期1255-1259,共5页 World Chinese Journal of Digestology
基金 国家自然科学基金资助项目 No.30771032 No.30700879 国家973 863重大项目子课题资助项目 No.2006CB503900 No.2006AA02A112 高等学校博士学科点专项科研基金资助项目 No.20050001146~~
关键词 基因转染 体细胞重构 干细胞 转录因子 Gene transfection Somatic cell reprogramming Stem cell Transcription factor
  • 相关文献

参考文献3

二级参考文献9

共引文献41

同被引文献40

  • 1胡彦营,王传美.胚胎干细胞技术的研究进展[J].生物技术通报,2007,23(4):90-92. 被引量:2
  • 2Reubinoff BE, Pera MF, Fong CY, et al. Embryonic stem cell lines from human blastocysts:somatic differentiation in vitro [J]. Nat Biotechnol. 2000. 18:399-404.
  • 3Kehat I, Kenyagin KD, Snir M, et al. Human embryonic stem cells can differentiate into myocytes with structural and function properities of cardiomyocytes [J]. Clin Invest, 2001,108:407-414.
  • 4Nichols J, Zevnik B, Anastassiadis K, et al. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4[J]. Cell, 1998,95:379-39.
  • 5Avilion A, Nicolis, SK, Pevny, LH, et al. Multipotent cell lineages in early mouse development depend on SOX2 function [J]. Genes Dev, 2003, 17:126-140.
  • 6Chambers I, Colby D, Robertson M, et al. Functional expression cloning of nanog, a pluripotency sustaining factor in embryonic stem cells[J]. Cell, 2003, 113:643-655.
  • 7Matsuda T, Nakamum T, Nakao, et al. STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells[J]. EMBO,1999,18:4261-4269.
  • 8Takahashi K, Mitsui K, Yamanaka S. Role of ERas in promoting tumour-like properties in mouse embryonic stem cells [J]. Nature, 2003,423:541-545.
  • 9Cartwright P, McLean C, Sheppard A, et al. LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism[J]. Development, 2005, 132:885-896.
  • 10Li Y, McClintick J, Zhong L, et al. Murine embryonic stem cell differentiation is promoted by SOCS-3 and inhibited by the zinc finger transcription factor Klf4[J]. Blood, 2005, 105:635-637.

引证文献2

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部